Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective

Eran Ben-Arye; Jun Mao; Eduardo Bruera; Noah Samuels; Yael Keshet; Richard T. Lee; Dina Ben-Yehuda; Elon Eisenberg; Gil Bar-Sela; Pesach Shvartzman; Lynda G. Balneaves; Michal Shani; Martin Ellis; Debu Tripathy; Shifra Ash; Avishay Elis; Zvi Vaknin; Ruth Ofir; Elad Schiff

doi:10.1016/j.jpainsymman.2023.09.022

Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective

Eran Ben-Arye^*, Jun Mao, Eduardo Bruera, Noah Samuels, Yael Keshet, Richard T. Lee, Dina Ben-Yehuda, Elon Eisenberg, Gil Bar-Sela, Pesach Shvartzman, Lynda G. Balneaves, Michal Shani, Martin Ellis, Debu Tripathy, Shifra Ash, Avishay Elis, Zvi Vaknin, Ruth Ofir, Elad Schiff

^*Corresponding author for this work

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Context and objectives: To explore the feasibility of implementing the joint guideline on integrative medicine for pain management in oncology, published by the Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO), for integrative oncology (IO) services in supportive and palliative care. Methods: A qualitative research methodology was co-designed by the SIO-ASCO guideline committee, with the Society for Complementary Medicine, Israel Medical Association (IMA). A questionnaire with five open-ended questions exploring barriers and enablers to implementing the guideline was distributed to chairs and board members of nine IMA-affiliated medical societies; four deans of Israeli medical schools; and nurses from the Israeli Society for Oncology Nursing. Respondent narratives were qualitatively analyzed using ATLAS.Ti software for systematic coding. Results: Questionnaires were completed by 52 physicians and nurses from medical oncology, hematology, gynecological oncology, pediatric oncology, palliative medicine, pain, family medicine, internal medicine, and integrative medicine. The SIO-ASCO guidelines were endorsed by nine IMA-affiliated societies. The domains identified included the importance of guideline implementation in clinical practice; barriers and facilitators to implementation; practical aspects required for this implementation (e.g., IO training); clinical indications for referral; budget-related issues; and clinical and administrative models enabling practical implementation of the guideline. Conclusion: We found across-the-board consensus among the nine IMA-affiliated societies supporting the current guideline. This, while identifying potential facilitators and barriers in order to address the implementation of the SIO-ASCO guideline recommendations.

Original language	American English
Journal	Journal of Pain and Symptom Management
DOIs	https://doi.org/10.1016/j.jpainsymman.2023.09.022
State	Accepted/In press - 2023

Bibliographical note

Funding Information:
All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that they have received no support from any organization for the submitted work; have no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. We are grateful to Heather Greenlee and the Society for Integrative Oncology Guideline Committee and executive Committee for supporting this study. Our gratitude to all those who completed or assisted in completion of questionnaires. Ethical approval: Participation in this study was voluntary.

Publisher Copyright:
© 2023 American Academy of Hospice and Palliative Medicine

Keywords

Cancer
guideline
integrative medicine
integrative oncology
israel
pain
palliative care

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jpainsymman.2023.09.022

Cite this

Ben-Arye, E., Mao, J., Bruera, E., Samuels, N., Keshet, Y., Lee, R. T., Ben-Yehuda, D., Eisenberg, E., Bar-Sela, G., Shvartzman, P., Balneaves, L. G., Shani, M., Ellis, M., Tripathy, D., Ash, S., Elis, A., Vaknin, Z., Ofir, R., & Schiff, E. (Accepted/In press). Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective. Journal of Pain and Symptom Management. https://doi.org/10.1016/j.jpainsymman.2023.09.022

@article{5c64e36c02d642f6aedd7161e0396f8f,

title = "Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective",

abstract = "Context and objectives: To explore the feasibility of implementing the joint guideline on integrative medicine for pain management in oncology, published by the Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO), for integrative oncology (IO) services in supportive and palliative care. Methods: A qualitative research methodology was co-designed by the SIO-ASCO guideline committee, with the Society for Complementary Medicine, Israel Medical Association (IMA). A questionnaire with five open-ended questions exploring barriers and enablers to implementing the guideline was distributed to chairs and board members of nine IMA-affiliated medical societies; four deans of Israeli medical schools; and nurses from the Israeli Society for Oncology Nursing. Respondent narratives were qualitatively analyzed using ATLAS.Ti software for systematic coding. Results: Questionnaires were completed by 52 physicians and nurses from medical oncology, hematology, gynecological oncology, pediatric oncology, palliative medicine, pain, family medicine, internal medicine, and integrative medicine. The SIO-ASCO guidelines were endorsed by nine IMA-affiliated societies. The domains identified included the importance of guideline implementation in clinical practice; barriers and facilitators to implementation; practical aspects required for this implementation (e.g., IO training); clinical indications for referral; budget-related issues; and clinical and administrative models enabling practical implementation of the guideline. Conclusion: We found across-the-board consensus among the nine IMA-affiliated societies supporting the current guideline. This, while identifying potential facilitators and barriers in order to address the implementation of the SIO-ASCO guideline recommendations.",

keywords = "Cancer, guideline, integrative medicine, integrative oncology, israel, pain, palliative care",

author = "Eran Ben-Arye and Jun Mao and Eduardo Bruera and Noah Samuels and Yael Keshet and Lee, {Richard T.} and Dina Ben-Yehuda and Elon Eisenberg and Gil Bar-Sela and Pesach Shvartzman and Balneaves, {Lynda G.} and Michal Shani and Martin Ellis and Debu Tripathy and Shifra Ash and Avishay Elis and Zvi Vaknin and Ruth Ofir and Elad Schiff",

note = "Funding Information: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that they have received no support from any organization for the submitted work; have no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. We are grateful to Heather Greenlee and the Society for Integrative Oncology Guideline Committee and executive Committee for supporting this study. Our gratitude to all those who completed or assisted in completion of questionnaires. Ethical approval: Participation in this study was voluntary. Publisher Copyright: {\textcopyright} 2023 American Academy of Hospice and Palliative Medicine",

year = "2023",

doi = "10.1016/j.jpainsymman.2023.09.022",

language = "American English",

journal = "Journal of Pain and Symptom Management",

issn = "0885-3924",

publisher = "Elsevier Inc.",

}

Ben-Arye, E, Mao, J, Bruera, E, Samuels, N, Keshet, Y, Lee, RT, Ben-Yehuda, D, Eisenberg, E, Bar-Sela, G, Shvartzman, P, Balneaves, LG, Shani, M, Ellis, M, Tripathy, D, Ash, S, Elis, A, Vaknin, Z, Ofir, R & Schiff, E 2023, 'Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective', Journal of Pain and Symptom Management. https://doi.org/10.1016/j.jpainsymman.2023.09.022

TY - JOUR

T1 - Challenges in Implementing Guideline on Integrative Oncology and Pain

T2 - The Israeli Perspective

AU - Ben-Arye, Eran

AU - Mao, Jun

AU - Bruera, Eduardo

AU - Samuels, Noah

AU - Keshet, Yael

AU - Lee, Richard T.

AU - Ben-Yehuda, Dina

AU - Eisenberg, Elon

AU - Bar-Sela, Gil

AU - Shvartzman, Pesach

AU - Balneaves, Lynda G.

AU - Shani, Michal

AU - Ellis, Martin

AU - Tripathy, Debu

AU - Ash, Shifra

AU - Elis, Avishay

AU - Vaknin, Zvi

AU - Ofir, Ruth

AU - Schiff, Elad

N1 - Funding Information: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that they have received no support from any organization for the submitted work; have no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. We are grateful to Heather Greenlee and the Society for Integrative Oncology Guideline Committee and executive Committee for supporting this study. Our gratitude to all those who completed or assisted in completion of questionnaires. Ethical approval: Participation in this study was voluntary. Publisher Copyright: © 2023 American Academy of Hospice and Palliative Medicine

PY - 2023

Y1 - 2023

N2 - Context and objectives: To explore the feasibility of implementing the joint guideline on integrative medicine for pain management in oncology, published by the Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO), for integrative oncology (IO) services in supportive and palliative care. Methods: A qualitative research methodology was co-designed by the SIO-ASCO guideline committee, with the Society for Complementary Medicine, Israel Medical Association (IMA). A questionnaire with five open-ended questions exploring barriers and enablers to implementing the guideline was distributed to chairs and board members of nine IMA-affiliated medical societies; four deans of Israeli medical schools; and nurses from the Israeli Society for Oncology Nursing. Respondent narratives were qualitatively analyzed using ATLAS.Ti software for systematic coding. Results: Questionnaires were completed by 52 physicians and nurses from medical oncology, hematology, gynecological oncology, pediatric oncology, palliative medicine, pain, family medicine, internal medicine, and integrative medicine. The SIO-ASCO guidelines were endorsed by nine IMA-affiliated societies. The domains identified included the importance of guideline implementation in clinical practice; barriers and facilitators to implementation; practical aspects required for this implementation (e.g., IO training); clinical indications for referral; budget-related issues; and clinical and administrative models enabling practical implementation of the guideline. Conclusion: We found across-the-board consensus among the nine IMA-affiliated societies supporting the current guideline. This, while identifying potential facilitators and barriers in order to address the implementation of the SIO-ASCO guideline recommendations.

AB - Context and objectives: To explore the feasibility of implementing the joint guideline on integrative medicine for pain management in oncology, published by the Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO), for integrative oncology (IO) services in supportive and palliative care. Methods: A qualitative research methodology was co-designed by the SIO-ASCO guideline committee, with the Society for Complementary Medicine, Israel Medical Association (IMA). A questionnaire with five open-ended questions exploring barriers and enablers to implementing the guideline was distributed to chairs and board members of nine IMA-affiliated medical societies; four deans of Israeli medical schools; and nurses from the Israeli Society for Oncology Nursing. Respondent narratives were qualitatively analyzed using ATLAS.Ti software for systematic coding. Results: Questionnaires were completed by 52 physicians and nurses from medical oncology, hematology, gynecological oncology, pediatric oncology, palliative medicine, pain, family medicine, internal medicine, and integrative medicine. The SIO-ASCO guidelines were endorsed by nine IMA-affiliated societies. The domains identified included the importance of guideline implementation in clinical practice; barriers and facilitators to implementation; practical aspects required for this implementation (e.g., IO training); clinical indications for referral; budget-related issues; and clinical and administrative models enabling practical implementation of the guideline. Conclusion: We found across-the-board consensus among the nine IMA-affiliated societies supporting the current guideline. This, while identifying potential facilitators and barriers in order to address the implementation of the SIO-ASCO guideline recommendations.

KW - Cancer

KW - guideline

KW - integrative medicine

KW - integrative oncology

KW - israel

KW - pain

KW - palliative care

UR - http://www.scopus.com/inward/record.url?scp=85174013119&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2023.09.022

DO - 10.1016/j.jpainsymman.2023.09.022

M3 - Article

C2 - 37769821

AN - SCOPUS:85174013119

SN - 0885-3924

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

ER -

Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this